Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.
Tuncel
M
M
Department of Nuclear Medicine, Hacettepe University Medical Faculty, Ankara, Turkey. muratmtx@yahoo.com
Ozgen Kiratli
P
P
D018263:Adenocarcinoma, Follicular / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D000328:Adult; D001808:Blood Vessels / Q000378:metabolism*; D001940:Breast / Q000098:blood supply / Q000000981:diagnostic imaging; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008479:Mediastinal Neoplasms / Q000556:secondary*; D008482:Mediastinum / Q000098:blood supply / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D013670:Sodium Pertechnetate Tc 99m / Q000493:pharmacokinetics*; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics*; D013964:Thyroid Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D013965:Thyroidectomy; D015899:Tomography, Emission-Computed, Single-Photon
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D013670:Sodium Pertechnetate Tc 99m